FOLFOXIRI in combination with panitumumab as first-line treatment in quadruple wild-type (KRAS, NRAS, HRAS, BRAF) metastatic colorectal cancer patients: a phase II trial by the Gruppo Oncologico Nord Ovest (GONO)
Titel:
FOLFOXIRI in combination with panitumumab as first-line treatment in quadruple wild-type (KRAS, NRAS, HRAS, BRAF) metastatic colorectal cancer patients: a phase II trial by the Gruppo Oncologico Nord Ovest (GONO)
Auteur:
Fornaro, L. Lonardi, S. Masi, G. Loupakis, F. Bergamo, F. Salvatore, L. Cremolini, C. Schirripa, M. Vivaldi, C. Aprile, G. Zaniboni, A. Bracarda, S. Fontanini, G. Sensi, E. Lupi, C. Morvillo, M. Zagonel, V. Falcone, A.